title: A Review of Clinical Translation of Inorganic Nanoparticles.
abstract: Inorganic nanoparticles are widely used for therapeutic and diagnostic purposes as they offer unique features as compared with their organic and polymeric counterparts. As such, inorganic nanoparticles represent an exciting opportunity to develop drug delivery and imaging systems that are poised to tackle unique challenges which are currently unaddressed in clinical settings. Despite these clear advantages, very few inorganic nanoparticle systems have entered the clinic. Here, we review the current clinical landscape of inorganic nanoparticle systems and their opportunities and challenges, with particular emphasis on gold-, iron-oxide- and silica-based nanoparticle systems. Key examples of inorganic nanoparticles that are currently being investigated in the clinic (e.g., trials which are recruiting or currently active but not completed) are highlighted, along with the preclinical work that these examples have leveraged to transition from the lab to the clinic.
authors.affiliation: Department of Chemical Engineering, Center for Bioengineering, University of California, Santa Barbara, California, 93106, USA.
authors.forename: Aaron C
authors.initials: AC
authors.lastname: Anselmo
authors.forename: Samir
authors.initials: S
authors.lastname: Mitragotri
mesh_terms: D000818:Animals; D003952:Diagnostic Imaging / Q000379:methods*; D016503:Drug Delivery Systems; D005290:Ferric Compounds / Q000737:chemistry; D006046:Gold / Q000737:chemistry; D006801:Humans; D053758:Nanoparticles; D012822:Silicon Dioxide / Q000737:chemistry
chemical_list: D005290:Ferric Compounds; C000499:ferric oxide; D006046:Gold; D012822:Silicon Dioxide